Page 117 - AN-3-2

Advanced Neurology Cerebrovascular pathology biomarkers in post-COVID-19 patients

12. Ruenjaiman V, Sodsai P, Kueanjinda P, et al. Impact of 21. Kitselman KA, Bédard-Matteau J, Rousseau S, et al. Sex
SARS-CoV-2 infection on the profiles and responses of differences in vascular endothelial function related to acute
innate immune cells after recovery. J Microbiol Immunol and long COVID-19. Vasc Pharmacol. 2024;154:107250.
Infect. 2022;55:993-1004.
doi: 10.1016/j.vph.2023.107250
doi: 10.1016/j.jmii.2022.09.001
22. Birnhuber A, Fliesser E, Gorkiewicz G, et al. Between
13. Willems LH, Nagy M, Ten Cate H, et al. Sustained inflammation and thrombosis: Endothelial cells in
inflammation, coagulation activation and elevated COVID-19. Eur Respir J. 2021;58:2100377.
endothelin-1 levels without macrovascular dysfunction at doi: 10.1183/13993003.00377-2021
3 months after COVID-19. Thromb Res. 2022;209:106-114.
23. Ong SW, Fong SW, Young BE, et al. Persistent symptoms
doi: 10.1016/j.thromres.2021.11.027
and association with inflammatory cytokine signatures in
14. Turgunova L, Mekhantseva I, Laryushina Y, et al. The recovered coronavirus disease 2019 patients. Open Forum
association of Endothelin-1 with early and long-term Infect Dis. 2021;8:ofab156.
mortality in COVID-19. Pers Med. 2023;13(11):1558.
doi: 10.1093/ofid/ofab156
doi: 10.3390/jpm13111558
24. Abraham GR, Kuc RE, Althage M, et al. Endothelin-1
15. Morichi S, Morishita N, Takeshita M, et al. Vascular is increased in the plasma of patients hospitalized with
endothelial growth factor (VEGF) and platelet-derived Covid-19. J Mol Cell Cardiol. 2022;167:92-96.
growth factor (PDGF) levels in the cerebrospinal fluid of doi: 10.1016/j.yjmcc.2022.03.007
children with influenza-associated encephalopathy. J Infect
Chemother. 2017;23(2):80-84. 25. Haffke M, Freitag H, Rudolf G, et al. Endothelial dysfunction
and altered endothelial biomarkers in patients with post-
doi: 10.1016/j.jiac.2016.10.007
COVID-19 syndrome and chronic fatigue syndrome
16. Alkharsah KR. VEGF upregulation in viral infections (ME/CFS). J Transl Med. 2022;20:138.
and its possible therapeutic implications. Int J Mol Sci. doi: 10.1186/s12967-022-03346-2
2018;19(6):1642.
26. Vassiliou AG, Vrettou CS, Keskinidou C, et al.
doi: 10.3390/ijms19061642
Endotheliopathy in acute COVID-19 and long COVID. Int J
17. Jin JM, Bai P, He W, et al. Gender differences in patients with Mol Sci. 2023;24(9):8237.
COVID-19: Focus on severity and mortality. Front Public doi: 10.3390/ijms24098237
Health. 2020;8:152.
27. Notarte KI, Catahay JA, Velasco JV, et al. Impact of COVID-19
doi: 10.3389/fpubh.2020.00152
vaccination on the risk of developing long-COVID and
18. Li X, Liu L, Yang Y, et al. Gender-associated difference on existing long-COVID symptoms: A systematic review.
following COVID-19 virus infection: Implications EClinicalMedicine. 2022;53:101624.
for thymosin alpha-1 therapy. Int Immunopharmacol. doi: 10.1016/j.eclinm.2022.101624
2021;90:107022.
28. Zhu X, Gebo KA, Abraham AG, et al. Dynamics of
doi: 10.1016/j.intimp.2020.107022
inflammatory responses after SARS- CoV-2 infection by
19. Stein DF, Foley C, Byott M, et al. Biological sex is associated vaccination status in the USA: A prospective cohort study.
with heterogeneous responses to IL-6 receptor inhibitor Lancet. 2023;4(9):e692-e703.
treatment in COVID-19-A retrospective cohort study. Sci doi: 10.1016/S2666-5247(23)00171-4
Rep. 2023;13(1):13504.
29. Talotta R. Impaired VEGF-A-mediated neurovascular
doi: 10.1038/s41598-023-40744-y
crosstalk induced by SARS-CoV-2 spike protein: A potential
20. Froldi G, Dorigo P. Endothelial dysfunction in Coronavirus hypothesis explaining long COVID-19 symptoms
disease 2019 (COVID-19): Gender and age influences. Med and COVID-19 vaccine side effects? Microorganisms.
Hypotheses. 2020;144:110015. 2022;10(12):2452.
doi: 10.1016/j.mehy.2020.110015 doi: 10.3390/microorganisms10122452

Volume 3 Issue 2 (2024) 8 doi: 10.36922/an.2878